Press Releases
 
Kidney Cancer Drugs Market to Surge at a CAGR of 6.6% by 2020

US, 13 January 2018 -- Kidney Cancer Drugs Market - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

The global kidney cancer drugs market is dominated by a few global giants, namely F. Hoffmann-La Roche Ltd., Bayer AG, Novartis AG, GlaxoSmithKline plc, and Pfizer, Inc. This makes the competitive landscape highly consolidated in nature. Competition among the players is stiff too.

Biopharmaceutical behemoth Pfizer, Inc., among them, led the global market for kidney cancer drugs with maximum share in 2013 on the back of Sunitinib and Axitinib, two of the main drugs used for treating kidney cancer. Other big names in the industry, such as Novartis and GSK too are adopting other strategies to increase their geographical outreach. They are focusing on bolstering their distribution networks in the relatively underserved markets in the emerging nations that are seeing an increasing prevalence of kidney cancer cases.

View Report Overview: http://www.transparencymarketresearch.com/kidney-cancer-drugs-market.html

A report by Transparency Market Research predicts the global market for kidney cancer drugs to expand at a 6.6% CAGR during the period between 2014 and 2020.  

North America Market Leads on the Back of Commercial Availability of Drugs from Prominent Brands

Depending upon the prominent brands of drugs, the global market for kidney cancer drugs can be segmented into Avastin (Bevacizumab), Afinitor (Everolimus), Inlyta (Axitinib), Torisel (Temsirolimus), Nexavar (Sorafenib), Sutent (Sunitinib), Proleukin (Aldesleukin/Interleukin-2), and Votrient (Pazopanib). Of them, Sutent, which is the marketed version of Sunitinib – Pfizer’s drug in the global kidney cancer drugs market, raked in maximum revenue in 2013. This is because Sutent is mainly prescribed as the first-line of treatment against kidney cancer. Sutent is also among the most studied drugs in its class for multiple indications, as it targets multiple receptor tyrosine kinases (RTKs).

Request to view Sample of Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=537

Geography-wise, the key segments of the global market for kidney cancer drugs are North America, Europe, Asia Pacific, and the Rest of the World (RoW). North America, among them, accounts for maximum market share owing to most prominent brands of kidney cancer treatment drugs being commercially available. In addition, a substantial number of patients and a solid healthcare system tailor-made for the pharmaceutical industry is also majorly fuelling the market in the region. North America accounted for 45% of market share in 2013.

Rising Population of Geriatrics Highly Susceptible to Kidney Cancer Driving Market

The global market for kidney cancer drugs is predicted to clock steady growth in the upcoming years because of an increasing geriatric population and higher prevalence of kidney cancer. As per the American Cancer Society, those afflicted with kidney cancer are mostly in the higher age bracket. The average age of people diagnosed with the malady is 64. Kidney cancer is very uncommon in people under the age of 45. The organization also finds that kidney cancer is one of the 10 most common cancers in both men and women.

Buy Kidney Cancer Drugs Market Research Report: https://www.transparencymarketresearch.com/checkout.php?rep_id=537<ype=S

Approval of novel drug molecules is also serving to catalyze growth in the global kidney cancer drugs market. Posing a challenge to the market, on the contrary, is the growing sales of generic drug variants on account of expensiveness of branded cancer drugs.

A trend noticed in the global market for kidney cancer drugs is the manufacturers shifting their gaze towards developing economies to bring about sales growth.

This review is based on the findings of a TMR report, titled, “Kidney Cancer Drugs Market (Major Drugs: Afinitor (Everolimus), Avastin (Bevacizumab), Inlyta (Axitinib), Nexavar (Sorafenib), Proleukin (Aldesleukin), Sutent (Sunitinib), Torisel (Temsirolimus), Votrient (Pazopanib)) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends, and Forecast 2014 - 2020.”

# # #


Media Contacts:
Contact us:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Submitted by Sandy Researcher, Transparency Market Research on Saturday, 13 January 2018 at 5:22 PM
Category: Health Care & Medical
 
Related News

Compression Therapy Market will going to be Worth US$4.25 Bn by the End of 2024
Tuesday, 25 Sep 2018

Preimplantation Genetic Diagnosis Market is Projected to Report a CAGR of 6.8% between 2015 and 2023
Tuesday, 25 Sep 2018

Compression Therapy Market will going to be Worth US$4.25 Bn by the End of 2024
Tuesday, 25 Sep 2018

Auto-Injectors Market to Rise to US$2.5 bn by the end of 2020
Tuesday, 25 Sep 2018

Pressure Ulcers Treatment Market is Expanding at a CAGR of 5% by 2026
Tuesday, 25 Sep 2018

Related Events

Imaging In Hawaii
Monday, 24 Sep 2018

2nd Safety Labeling and Packaging Summit
Monday, 24 Sep 2018

Medical Affairs Strategic Summit (MASS) West 2018
Monday, 24 Sep 2018

22nd International Surgical Pathology Symposium, Venice, Italy / Sep 25-28
Tuesday, 25 Sep 2018

43rd World Small Animal Veterinary Congress and 9th FASAVA Congress
Tuesday, 25 Sep 2018

Latest News

Bitcoin Casino Have Excellent Deal of Benefits Even for Bitcoin Users
Tuesday, 25 Sep 2018

Audio Live - Phone Call Services
Tuesday, 25 Sep 2018

Compression Therapy Market will going to be Worth US$4.25 Bn by the End of 2024
Tuesday, 25 Sep 2018

Australia Latest News
Tuesday, 25 Sep 2018

Preimplantation Genetic Diagnosis Market is Projected to Report a CAGR of 6.8% between 2015 and 2023
Tuesday, 25 Sep 2018

 
Want to get your press releases, event listings, and job ads on Scoopasia? Register now for a FREE account or login if you already have one!
Scoopasia v1.0b. Copyright © 2018
Today is Tuesday, 25 September 2018

About Scoopasia | FAQ | Privacy Policy | Contact Us

Press Releases
Event Listings
Job Listings
Arts & Entertainment
Architecture & Construction
Automotive & Travel
Business
Consumer Technology
Economy
Education
Enterprise Technology
Food & Fashion
Government & Policy
Health Care & Medical
Legal/Law
News & Media
Religion
Science & Research
Sports & Fitness
Login / Register
Get Scoopasia through RSS Feeds & Email Notifications!


Journalist's Toolbox
Hello journalist, welcome to Scoopasia--a powerful online resource for media information in Asia. Scoopasia has press releases and media events for every beat and industry. All content on Scoopasia is 100% FREE. You don't even need to login!

  • Scoop Line
    (Instant Information Request)
    The easiest way to ask questions and request information from the PR community.


  • Advanced Search
    Drill down, dig deep, for media information the way you want it.

  • Journalist's Resources
    Resources and tools you can't do without.

  • PR Tools
    Scoopasia Blog Search
    Search the largest handpicked collection of Asia's most prominent and influential blogs.


    Resources
  • PR Bookmarks
  • Web 2.0 Bookmarks
  • Media Bookmarks

    More Coming Soon...

  • Upcoming Events
  • Imaging In Hawaii
  • 2nd Safety Labeling and Packaging Summit
  • Medical Affairs Strategic Summit (MASS) West 2018
  • Chemical Development and Scale-Up, Prague, Czech Republic
  • Africa Fertilizer Agribusiness Conference 2018

  • Latest Jobs
    Sorry, there are currently no entries posted here.